ArticleResearch and practice in thrombosis and haemostasis2023

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.

Cedric Hermans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.